Login / Signup

Real-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey.

Matthew J PingreeMark Fb HurdleDavid A SpinnerAli ValimahomedNathan D CrosbyJoseph W Boggs
Published in: Pain management (2022)
Objective: This study presents real-world data from a cross-sectional follow-up survey of patients who previously received 60-day peripheral nerve stimulation (PNS) treatment for pain. Materials & methods: A survey including validated pain and other related outcome measures was distributed to patients who previously underwent implantation of temporary PNS leads for 60-day PNS treatment. Results: Among survey respondents who were at least 3 months from the start of treatment, most reported sustained clinically significant improvements in pain and/or quality of life, with the length of follow-up at the time of survey completion ranging from 3 to 30 months. Conclusion: These real-world data support recent prospective studies indicating that 60-day percutaneous PNS provides significant and sustained relief across a wide range of pain conditions.
Keyphrases
  • chronic pain
  • pain management
  • neuropathic pain
  • cross sectional
  • peripheral nerve
  • spinal cord
  • minimally invasive
  • artificial intelligence
  • chemotherapy induced